What Happened
- The Central Government told the Supreme Court that the existing ban on blood donation by transgender persons, men who have sex with men (MSM), and female sex workers (FSW) would be retained, following review by a fresh expert committee constituted in May 2025.
- The expert committee submitted its report in August 2025, concluding that the 2017 Blood Donor Selection and Blood Donor Referral Guidelines are "firmly rooted in national and international research" and that any relaxation could pose a serious risk to the safety and integrity of the national blood supply.
- The government argued that the right of the recipient to receive a safe blood transfusion outweighs the right of an individual to donate blood, framing this as a public health necessity rather than discrimination.
- HIV prevalence among these groups is cited as 6 to 13 times higher than in the general adult population, justifying the permanent deferral classification under Clause 51 of the 2017 guidelines.
- Petitioners challenged Clauses 12 and 51 of the guidelines as violating Articles 14 (equality), 15 (non-discrimination), and 21 (right to life and dignity) of the Constitution.
Static Topic Bridges
Fundamental Rights: Articles 14, 15, and 21 — Equality, Non-Discrimination, and Dignity
Articles 14, 15, and 21 form the core of the fundamental rights architecture in Part III of the Constitution and are frequently invoked in cases involving differential treatment of marginalised groups.
- Article 14 guarantees equality before law and equal protection of laws; it permits "reasonable classification" but prohibits arbitrary distinctions.
- Article 15 prohibits discrimination on grounds of religion, race, caste, sex, or place of birth; the Supreme Court in Navtej Singh Johar (2018) read sexual orientation as a protected ground under Article 15.
- Article 21 has been expansively interpreted to include the right to health, dignity, and bodily autonomy — all of which petitioners argued are violated by a permanent, identity-based donation ban with no individual risk assessment pathway.
- The State's defence — that recipient safety justifies the restriction — invokes the "reasonable restriction" doctrine applicable under Articles 19 and 21, balancing individual rights against public health.
Connection to this news: The case is a direct constitutional challenge testing whether public health justifications can sustain categorical exclusions based on identity rather than individual behaviour or test results.
National Blood Policy and Transfusion Safety Regulation
India's blood transfusion system is governed by the National Blood Policy (2007), the Drugs and Cosmetics Act, 1940, and the 2017 National Blood Transfusion Council (NBTC) and National AIDS Control Organisation (NACO) guidelines. The 2017 guidelines replaced earlier standards and introduced the permanent deferral category.
- National Blood Transfusion Council (NBTC) under the Ministry of Health sets standards; Blood Banks are licensed under the Drugs and Cosmetics Act.
- The 2017 Guidelines classify donors into categories based on risk of Transfusion-Transmitted Infections (TTIs) — including HIV, Hepatitis B, Hepatitis C, and syphilis.
- "Permanent deferral" means lifetime ineligibility with no reassessment pathway — distinct from "temporary deferral" (e.g., post-travel, post-illness) which allows re-entry.
- Several countries — the UK, US, France — shifted from permanent bans to "individualised assessment" models for MSM, removing categorical exclusions in favour of universal behavioural questionnaires applied to all donors.
Connection to this news: India's retention of the permanent deferral policy stands in contrast to an international trend toward individual risk-based assessment, placing the Supreme Court at the centre of a policy debate with both public health and human rights dimensions.
Transgender Rights Framework and NALSA Judgment
The Supreme Court's landmark NALSA judgment (2014) recognised transgender persons as a "third gender" and affirmed their fundamental rights under Articles 14, 15, 19, and 21. The Transgender Persons (Protection of Rights) Act, 2019, codified legal protections.
- NALSA v. Union of India (2014): Supreme Court directed Centre and states to take steps for social and educational inclusion of transgender persons and affirmed their right to self-identified gender.
- Transgender Persons (Protection of Rights) Act, 2019: prohibits discrimination in employment, education, healthcare, and access to government services.
- Section 3 of the 2019 Act specifically prohibits denial of healthcare services to transgender persons — petitioners argued the blood donation ban constitutes precisely such a denial.
- The Navtej Singh Johar judgment (2018) decriminalised consensual same-sex conduct by reading down Section 377 IPC — but did not automatically alter administrative guidelines like the blood donation rules.
Connection to this news: The Centre's position — retaining the permanent deferral even after NALSA and the Transgender Rights Act — creates a potential conflict between health regulation and the rights framework established by successive Supreme Court rulings.
Key Facts & Data
- HIV prevalence: MSM ~2.7%, transgender persons ~3.1%, FSW ~2.2% — compared to ~0.2% in the general adult population (NACO data).
- 2017 Guidelines Clause 12: categorises transgender persons, MSM, and FSW as "at risk" for transmissible infections.
- Clause 51: mandates permanent deferral — no waiting period, no individual assessment pathway.
- Expert committee: Constituted May 2025 per Supreme Court direction; report submitted August 2025; conclusion: retain the ban.
- Constitutional articles challenged: 14 (equality), 15 (non-discrimination), 21 (right to life and dignity).
- Comparable international policies: UK, US, France, and Canada shifted to individualised risk-based donor assessment for MSM.
- Petitioner: Thangjam Santa Singh, transgender rights activist.